Amneal Pharmaceuticals, Inc. - COM STK CL A (AMRX)

Q4 2019 13F Portfolio Holders as of 12/31/2019

Type / Class
Equity / COM STK CL A
Number of holders
116
Total Shares
101M
Shares change
-7.21M
Total reported value, excl. options
$488M
Value change
-$9.61M
Put/Call ratio
249.5
Number of buys
72
Number of sells
-46
Price
$4.82
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.